SILO

1.7109.04%
JW

Joshua Woolley

Member of Scientific Advisory Board

Dr. Joshua Woolley, B.Sc., M.D, Ph.D., also known as Josh, is Member of Scientific Advisory Board of Silo Pharma, Inc. He served as Member of Advisory Council at Filament Health Corp. until May 2024. He served as its Member of Scientific Advisory Board since November 2020 until October 2023. He is an Associate Professor in Residence, Department of Psychiatry and Behavioral Sciences at the University of California, San Francisco (UCSF). He is also a licensed psychiatrist on staff in Mental Health at the San Francisco Veterans Affairs Medical Center (SFVAMC). Throughout his career, Dr. Woolley has moved between the clinical and research laboratory, focusing his area of study on understanding and treating social cognitive deficits across various mental illness diagnoses. He is the principal investigator, Director and founder of the Bonding and Attunement in Neuropsychiatric Disorders (BAND) Laboratory. Dr. Woolley has been studying the mechanisms underlying social cognitive deficits found across different mental illness diagnoses including schizophrenia, posttraumatic stress disorder and substance use disorders. He is also investigating the psychobiological mechanisms underlying group cohesion and trust as well as developing pharmacologically enhanced group interventions for these psychiatric illnesses. Dr. Woolley received his bachelor’s degree from Brown University with a double major in Biology and Philosophy. He received both his MD and his PhD in Neuroscience from University of California, San Francisco and completed his psychiatry residency training at University of California, San Francisco.

Positions